1 January 2024 false No description of principal activity Taxfiler 2024.6 14540016 business:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14540016 2023-12-31 14540016 2024-01-01 2024-12-31 14540016 business:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 14540016 business:FilletedAccounts 2024-01-01 2024-12-31 14540016 2024-12-31 14540016 business:Director1 2024-01-01 2024-12-31 14540016 business:RegisteredOffice 2024-01-01 2024-12-31 14540016 2023-12-31 14540016 core:WithinOneYear 2024-12-31 14540016 core:WithinOneYear 2023-12-31 14540016 core:ShareCapital core:PreviouslyStatedAmount 2024-12-31 14540016 core:ShareCapital core:PreviouslyStatedAmount 2023-12-31 14540016 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-12-31 14540016 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2023-12-31 14540016 core:PreviouslyStatedAmount 2024-12-31 14540016 core:PreviouslyStatedAmount 2023-12-31 14540016 business:SmallEntities 2024-01-01 2024-12-31 14540016 countries:EnglandWales 2024-01-01 2024-12-31 14540016 business:OrdinaryShareClass1 2024-01-01 2024-12-31 14540016 business:OrdinaryShareClass1 2022-12-14 2023-12-31 14540016 2022-12-14 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14540016 (England and Wales)
Hawari Medical Group Limited Unaudited accounts for the year ended 31 December 2024
Hawari Medical Group Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Hawari Medical Group Limited Company Information for the year ended 31 December 2024
Director
Dr Amal El-Hawari
Company Number
14540016 (England and Wales)
Registered Office
53 Canford Lane Bristol BS9 3NX England
Accountants
Fabaci Financial Ltd 30 Ebbett Court Victoria Road London W3 6BW
- 3 -
Hawari Medical Group Limited Statement of financial position as at 31 December 2024
2024
2023
Notes
£
£
Current assets
Debtors
4
519
-
Cash at bank and in hand
81
100
600
100
Creditors: amounts falling due within one year
5
(3,755)
-
Net current (liabilities)/assets
(3,155)
100
Net (liabilities)/assets
(3,155)
100
Capital and reserves
Called up share capital
6
100
100
Profit and loss account
(3,255)
-
Shareholders' funds
(3,155)
100
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 October 2025 and were signed on its behalf by
Dr Amal El-Hawari Director Company Registration No. 14540016
- 4 -
Hawari Medical Group Limited Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Hawari Medical Group Limited is a private company, limited by shares, registered in England and Wales, registration number 14540016. The registered office is 53 Canford Lane, Bristol, BS9 3NX, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in GBP sterling.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
4
Debtors
2024
2023
£
£
Amounts falling due within one year
Other debtors
519
-
5
Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
3,500
-
Accruals
255
-
3,755
-
6
Share capital
2024
2023
£
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
7
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 5 -